Solaris Endovascular Announces Completion of Enrollment in DEScover Trial
Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical evidence of safety and performance.
NEW ORLEANS, LA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — Solaris Endovascular, …
